MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$8,331K
EPS
-$0.15
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
License revenue
0 0 70,000
Research and development
7,437 9,319 10,506
General and administrative
3,541 4,101 4,964
Total operating expenses
10,978 13,420 15,470
Income (loss) from operations
-10,978 -13,420 54,530
Interest income
1,164 1,118 595
Other income (expense)
1,316 1,741 1,417
Total other income (expense), net
2,480 2,859 2,012
Net income (loss)
-8,498 -10,561 56,542
Unrealized gain (loss) on investments, net
167 -6 -43
Comprehensive income (loss)
-8,331 -10,567 56,499
Net income (loss) per share basic (in dollars per share)
-0.15 -0.19 1
Net income (loss) per share, diluted (in dollars per share)
-0.15 -0.19 0.98
Weighted average common shares outstanding, basic (in shares)
56,929,103 56,803,450 56,663,798
Weighted average common shares outstanding, diluted (in shares)
56,929,103 56,803,450 57,673,099
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive income (loss)-$8,331K Unrealized gain (loss) oninvestments, net$167K Other income(expense)$1,316K Interest income$1,164K Net income (loss)-$8,498K Total other income(expense), net$2,480K Income (loss) fromoperations-$10,978K Total operatingexpenses$10,978K General andadministrative$3,541K Research and development$7,437K

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. (BDTX)